 MINNEAPOLIS, April 12, 2022 GLOBE NEWSWIRE -- CVRx, Inc. CVRx, a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release first quarter 2022 financial and operating results after market close on Monday, April 25th, 2022. The Company will host a conference call to review its results at 4:30 p.m. Eastern Time the same day. 